[EN] TOLL-LIKE RECEPTOR 4 (TLR4) INHIBITORS AND USE THEREOF<br/>[FR] INHIBITEURS DU RÉCEPTEUR 4 DE TYPE TOLL (TLR4) ET LEUR UTILISATION
申请人:MOR RESEARCH APPLIC LTD
公开号:WO2019224754A1
公开(公告)日:2019-11-28
Peptides, peptidomimetics and small molecules, collectively referred to as "decoy peptides", are provided, which interfere with binding to a TIR domain of a toll-like receptor 4 (TLR4), and inhibit a TLR4-induced signaling pathway. These decoy peptides may be useful for treating diseases associated with induction of TLR4 signaling pathway such as a disease or disorder secondary to a cardiovascular disease, sepsis or an inflammatory disease.
提供肽、肽类似物和小分子,统称为“诱饵肽”,这些物质干扰与Toll样受体4(TLR4)的TIR结构域的结合,并抑制TLR4诱导的信号通路。这些诱饵肽可能对治疗与TLR4信号通路诱导相关的疾病有用,比如与心血管疾病、败血症或炎症性疾病相关的疾病或紊乱。